Back to
JPMORGAN CHASE & CO
AMLX8 quarters
Position history for
JPMORGAN CHASE & CO's holdings in AMYLYX PHARMACEUTICALS INC
Yes. JPMorgan Chase holds 1,863,650 shares of AMLX (Amylyx Pharmaceuticals), worth $34.9M, as of its Q2 2026 13F filing. It increased the position from 159,663 shares in Q1 2026. JPMorgan Chase has held AMLX in every 13F on record since Q3 2024, 8 quarterly filings.
Current Value
$34.9M
Current Shares
1.9M
Total Value Change
+$34.5M
Total Shares Change
+1.7M
Quarter-by-Quarter History
Other major holders of AMLX: FMR LLC, VIKING GLOBAL INVESTORS LP